| __timestamp | Gilead Sciences, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3788000000 | 1717000000 |
| Thursday, January 1, 2015 | 4006000000 | 1738000000 |
| Friday, January 1, 2016 | 4261000000 | 1666000000 |
| Sunday, January 1, 2017 | 4371000000 | 1775000000 |
| Monday, January 1, 2018 | 4853000000 | 1911000000 |
| Tuesday, January 1, 2019 | 4675000000 | 1992000000 |
| Wednesday, January 1, 2020 | 4572000000 | 2057000000 |
| Friday, January 1, 2021 | 6601000000 | 2303000000 |
| Saturday, January 1, 2022 | 5657000000 | 2454000000 |
| Sunday, January 1, 2023 | 6498000000 | 2710000000 |
| Monday, January 1, 2024 | 28675800000 | 2719000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis delves into the cost of revenue trends for Gilead Sciences, Inc. and Zoetis Inc. from 2014 to 2023.
Gilead Sciences, Inc. has seen a significant increase in its cost of revenue, peaking in 2021 with a 74% rise from 2014. This surge reflects the company's strategic investments and expansion efforts. Meanwhile, Zoetis Inc. has experienced a steady growth, with its cost of revenue increasing by 58% over the same period, indicating a consistent upward trajectory in its operational scale.
These insights highlight the dynamic nature of the pharmaceutical sector, where companies must balance cost management with growth strategies to maintain competitive advantage.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Gilead Sciences, Inc.
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Zoetis Inc. and Takeda Pharmaceutical Company Limited
Cost of Revenue: Key Insights for Zoetis Inc. and Intra-Cellular Therapies, Inc.
Analyzing Cost of Revenue: Zoetis Inc. and Catalent, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Jazz Pharmaceuticals plc
Cost of Revenue Comparison: Zoetis Inc. vs Lantheus Holdings, Inc.
Zoetis Inc. vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Zoetis Inc. and HUTCHMED (China) Limited
Zoetis Inc. vs Mesoblast Limited: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Zoetis Inc. and Evotec SE